Study of a sleep medication for people with Parkinson's and insomnia
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new sleep medicine called Dimdazenil for people with Parkinson's disease who also have trouble sleeping. The goal is to see if it helps improve sleep without making Parkinson's symptoms worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a diagnosis of Parkinson's disease and your symptoms are well controlled (you can move fairly well when your medication is working).
- You have insomnia, like taking more than 30 minutes to fall asleep, waking up often at night, or sleeping less than 6.5 hours, at least 3 times a week, and it bothers you during the day.
- You are on a stable Parkinson's medication (no changes for at least 4 weeks) and you don't have motor fluctuations (times when symptoms come back) or involuntary movements.
- You are willing to have a sleep study (polysomnography) and fill out sleep diaries.
- You have not used sedative sleeping pills (like benzodiazepines) in the last 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a sleep medication called lemborexant in people with Parkinson's disease who also have insomnia. The goal is to see if it improves both sleep and movement symptoms.
This study tests an experimental sleep aid called daridorexant for people who have both depression and insomnia. It aims to see if the drug can improve sleep without worsening depression symptoms.
This study follows adults with insomnia who are prescribed a new sleep medication called daridorexant. It aims to see how well the medication works in a real-world setting, and to monitor its safety and effects on sleep.
This study tests a sleep treatment given under anesthesia to help people with severe, long-lasting insomnia that hasn't improved with other treatments. It looks at whether this approach is safe and effective for improving sleep and daytime function.
This trial tests whether a part of the brain called the locus coeruleus is involved in insomnia. It involves sleep questionnaires and possibly brain imaging to understand your sleep problems better.
This trial tests a new medication, APSTZD, to see how well it works and how safe it is for people with insomnia, especially those who have trouble staying asleep through the night.
Hear when a new Insomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.